European Medical Journal4d
Rare Anti-HMGCR-Induced Immune-Mediated Necrotising Myopathy: A Case Report and Literature Review
An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...
WTVD4d
Smithfield teen takes second in national science contest for research on Native American myopathy
She centered her research for this national science contest around Native American myopathy, which is also known as stac3, which is a muscle disorder. Cummings tested adult flies and larvae and ...
Medscape15d
Therapy Insight: Cardiovascular Complications Associated With Muscular Dystrophy
The muscular dystrophies are commonly associated with cardiovascular complications, including cardiomyopathy and cardiac arrhythmias. These complications are caused by intrinsic defects in ...
Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition
FDA grants Priority Review to Capricor's deramiocel for Duchenne cardiomyopathy, setting an August 2025 decision date with no ...
FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that acceptance has been received by Capricor Therapeutics, Inc. (Headquarters: California, ...
Capricor Therapeutics' Cell Therapy for Muscular Dystrophy Patients to Get FDA Priority Review
The Food and Drug Administration has accepted Capricor Therapeutics' application seeking approval of its cell therapy deramiocel for muscular dystrophy patients and granted it a priority review. The ...
Monthly Prescribing Reference14d
Deramiocel Granted Priority Review for DMD Cardiomyopathy
The Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for deramiocel (CAP-1002) for the treatment of Duchenne muscular dystrophy (DMD) ...